Cat.#: ACPP-1186
| Despition | Olig2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1034 | Recombinant Human NG2 Protein (6×His Tag) (AC1034) | 50 µg | inquiry |
| ACPP-1003 | Recombinant Human NOTCH3 Protein (Fc Tag) (AC1003) | 50 µg | inquiry |
| ACPP-1250 | Lin28 Blocking Peptide (AC1250) | 250 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.